Evommune, Inc. Common Stock (EVMN)
EBITDA Growth
-63.15%
TTM · Period ending:
EVMN EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-63.15%period ending
Latest reported-63.15%period ending
EVMN TTM EBITDA YoY % (-9.53% → -63.15%)
Year-over-year change
High-resolution chart · PNG
EVMN ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -63.1523% | |
| -5.0789% | |
| -9.5342% |